Protocol for systematic review and meta-analysis on randomized clinical trials for direct oral anticoagulant in subjects with acute coronary syndrome.

Background: Recently, direct oral anticoagulant (DOAC) has been projected for secondary prevention of recurrent ischemic events post-acute coronary syndrome (ACS). The addition of a DOAC to the antiplatelet regimen of subjects with the ACS is clinically practiced in candidates where compelling antic...

Descripción completa

Detalles Bibliográficos

Publicado en:	Pharmacy Practice (1886-3655) Vol. 21; no. 2; pp. 1 - 11
Autores principales:	El Khidir, Israa Y., Elnour, Asim Ahmed, Al Amoodi, Abdulla, Alrashdi, Abrar Ayad, Almansour, Haifa Hamoud, Almarwani, Teif Abdulkarim, Alrowaili, Shahad Fayad, Al Khudhairy, Shouq Lutfi, Alshammari, Asma Faisal, Sadeq, Adel, Al Mazrouei, Nadia, Al-Kubaisi, Khalid Awad, EL Khidir, Hala Yousif, Alkaabi, Maisoun, Ashoor, Afaf
Formato:	protocol tables/charts Journal Article
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas S.L. Apr-Jun2023
Acceso en línea:	Ver este registro en EBSCOhost